Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 14INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Neoplasms 2870Carcinoma, Non-Small-Cell Lung 2420Breast Neoplasms 2065Colorectal Neoplasms 1239Neoplasm Metastasis 1223Prostatic Neoplasms 1076Melanoma 972Multiple Myeloma 960Ovarian Neoplasms 899Recurrence 849Leukemia, Myeloid, Acute 807Lung Neoplasms 756Pancreatic Neoplasms 750Lymphoma, Non-Hodgkin 726Lymphoma 660Stomach Neoplasms 622Carcinoma, Hepatocellular 564Carcinoma, Renal Cell 544Squamous Cell Carcinoma of Head and Neck 525Leukemia, Lymphocytic, Chronic, B-Cell 493Lymphoma, Follicular 468Head and Neck Neoplasms 449Glioblastoma 435Advanced Solid Tumors 430Small Cell Lung Carcinoma 408Triple Negative Breast Neoplasms 407Lymphoma, Large B-Cell, Diffuse 398Leukemia 394Uterine Cervical Neoplasms 367Advanced Solid Tumor 349

Interventions

Robotic Surgical Procedures 1Hysterectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Menstruation Disturbances × Clear all
NCT07120945 2026-03-06

Embrace Gyn

Medtronic - MITG

Phase NA Recruiting
70 enrolled
GynecologicOther neoplasm

Uterine Cervical Neoplasms, Endometriosis, Leiomyoma, Menstruation Disturbances, Ovarian Neoplasms, Precancerous Conditions, Uterine Prolapse, Endometrial Neoplasms, Adenomyosis

NCT02865915 2021-02-01

MLE4901 vs. Placebo for the Treatment of PCOS

Millendo Therapeutics, Inc.

Phase 2 Terminated
55 enrolled 10 charts

Acne Vulgaris, Alopecia, Hirsutism, Menstruation Disturbances, Polycystic Ovary Syndrome

NCT03673995 2020-06-16

Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS

Pharmarte srl

Phase NA Completed
186 enrolled

Hirsutism, Menstruation Disturbances, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡